Atypical bare nuclei on ThinPrep Pap tests are associated with high-grade lesions (HSIL or worse).
Stay Tuned to Important Updates in Gleason Grading
Current Perspectives on the Gleason Grading of Prostate Cancer. Shah RB: Arch Pathol Lab Med 2009; 133 (November): 1810 133 (November): -1816 The Gleason grading system has been revised and refined as the use of PSA screening has become widespread and as our understanding of the morphologic spectrum and outcomes of prostate cancer has improved.
Background: There has been a shift in disease staging toward low-volume, low-stage prostate cancer. This has resulted in important changes and practices in the Gleason grading of prostate cancer. Objective: To summarize current perspectives on the Gleason grading of prostate cancer. Discussion: First, a diagnosis of Gleason grade 1 or 2 should rarely, if ever, be made on a prostate biopsy. In practice, prostatectomy specimens almost always demonstrate higher grade tumor. From a practical standpoint, Gleason grading starts with pattern 3, that of variably sized individual glands infiltrating between benign glands. Second, most cribriform carcinomas are Gleason pattern 4. This histologic pattern includes large cribriform glands and cribriform glands with irregular borders or with ductal differentiation. It is associated with an aggressive course, and if comedonecrosis is present, a pattern of 5 should be considered. A pattern of 3 is reserved only for well-rounded, circumscribed cribriform glands that are the same size as normal glands. A Gleason grade of 4 should also be diagnosed for a large cluster of poorly formed glands without obvious lumina, that which is outside the spectrum of tangential sectioning. The reporting of Gleason grading, depending on how the cores are received, has also been reviewed. If the cores are received separately, it is fitting to assign a total Gleason score for each core. There are no guidelines addressing overall grading if the cores are combined for each side of the prostate. At our institution, we give a diagnosis that represents the "global" Gleason score for each side, representing the highest patterns seen among all cores. For management issues, it is important to report the highest pattern, even if it does not represent the primary or secondary pattern. Likewise, it is important to quantify the amount of the highest pattern. Intraductal carcinoma of the prostate (IDC-P) is a new and important entity. It is defined as "malignant epithelial cells filling large acini and prostatic ducts with at least partial preservation of basal cells forming either solid or dense cribriform patterns or loose cribriform/micropapillary patterns with either marked nuclear atypia or comedonecrosis." There is currently no standard reporting format, but at a minimum, this entity should be reported due to its association with high-grade invasive cancer. Finally, the grading of unusual subtypes of prostate adenocarcinoma is discussed. Reviewer's Comments: This article summarizes the current state of practice as well as the issues that we currently face in prostate biopsies in terms of Gleason grading and reporting. (Reviewer-Stacey E. Mills, MD).
No Stage Migration When ITCs Considered N0
More More tumor-affected lymph nodes have been detected in breast cancer patients since the introduction of the SLN biopsy. However, when isolated tumor cells are categorized as N0, there has been no stage migration.
Background: In recent years, sentinel lymph node (SLN) biopsy has become standard of care in select breast cancer patients to replace axillary lymph node dissection (ALND). Pathologists have intensified the protocols for handling these nodes, including serial sectioning, multiple levels, and immunohistochemical staining. One concern is that this may result in increased detection of tumor-affected lymph nodes and a resultant stage migration of these patients. Nodular fasciitis is an underrecognized lesion in the head and neck region, where it is distinctive for being smaller in size, having more prominent skeletal muscle invasion, and having strong and diffuse actin positivity.
Tertial Cutoffs of MI Need Validating for Breast Cancer Grading
Mitotic Index of Invasive Breast Carcinoma: Achieving Clinically Meaningful Precision and Evaluating Tertial Cutoffs.
Meyer JS, Cosatto E, Graf HP:
Arch Pathol Lab Med 2009; 133 (November): [1826] [1827] [1828] [1829] [1830] [1831] [1832] [1833] Counting mitotic figures in a single set of 10 HPFs has too much variability for clinical utility and 5 sets of 10 HPFs is recommended for cases with low mitotic rates.
Background: The Nottingham grading system relies on the mitotic index (MI) as determined by a count of 10 HPFs as 1 of 3 factors. While the histologic grade of breast carcinoma correlates to clinical outcome, there is a concern over suboptimal reproducibility among reviewers. Objective: To examine the precision and accuracy of evaluating MI using a coefficient of variation (CV). Methods: Breast carcinoma from routine service and from a cooperative tissue bank (weighted for nodenegative cancers) were included for review if at least 2 sets of 10 HPFs were present for formal evaluation. Mitotic counts were determined in >1 and up to 6 sets of 10 HPFs. While cellular and well-preserved areas were selected at low power, no effort was made to begin in a hot spot of mitotic figures. The fields were systematically counted with manual mechanical stages, but any field with poor cellularity was skipped. The MI represented the average across the sets of 10 HPFs, and then the tertial cutoffs were established by finding equal thirds by magnitude of the MI. Standard error and CVs were compared with expected results. Results: The tertial cutoff values for MI were 1.14 and 5.33. The mean CV was 147% for the lowest third, 72% for the middle, and 34.6% for the highest. Binomial probability accurately predicted the standard errors and CV, indicating poor reproducibility of mitotic counts in tumors with low MI. There was also a strong negative skew, indicating tertiary cutoffs that were incompatible with the established systems. Conclusions: MI based on mitotic count from a single set of 10 HPFs has too broad of a standard of error and too large of a coefficient of variation for clinical utility. Five sets of 10 HPFs should be considered in lesions with low mitotic rates. Reviewer's Comments: This study was weighted with node-negative carcinomas and may be biased toward lower grade tumors with a lower MI. The authors' conclusions of the Nottingham cutoff values being too high and 1 set of 10 HPFs being inefficient may be influenced by the population studied. (Reviewer-Mary T. Galgano, MD).
